Precision System Science Co., Ltd.
Precision System Science Corporation 2026 June Term Financial Summary
Sales of 5,216 million yen (YoY +11.2%), operating income turned positive at 201 million yen, net income attributable to owners of the parent improved to 394 million yen. For the year ending June 2027, sales are expected to be 5,650 million yen and operating income 350 million yen. Driving sales expansion of devices and reagents for genetic testing centered on the PSS platform, while cost containment is pursued. Net income significantly improves due to liquidation gains of the U.S. subsidiary and deferred tax assets recognized, among other factors.
Key Figures
- Sales: 5,216 million yen
- Operating income: 201 million yen
- Net income attributable to owners of the parent: 394 million yen
- Next period outlook: Sales 5,650 million yen, Operating income 350 million yen
- Number of treasury shares: 53,603 thousand yen (end-of-term treasury share amount)
AI要約
Overview of Results
This fiscal term's results show sales of 5,216 million yen, up 11.2% YoY. The effects of reduced selling, general and administrative expenses and restructuring contributed to turning operating income positive at 201 million yen, with ordinary income of 155 million yen. Net income attributable to owners of the parent improved to 394 million yen. By component, sales were 2,231 million yen for devices, 2,037 million yen for reagents and consumables, and 948 million yen for services and others. Sales growth from devices and nucleic acid extraction reagents using the PSS platform contributed to the improvement.
Outlook and Capital Measures
For the consolidated results of the year ending June 2027, sales are expected to be 5,650 million yen, operating income 350 million yen, ordinary income 298 million yen, and net income attributable to owners of the parent 292 million yen. The company plans to secure a foundation of long-term stable orders through an OEM agreement with ELITechGroup. Financially, cash flow is stable, and the company will continue expanding the PSS platform while advancing business restructuring and cost reduction to improve profitability.
Precision System Science Corporation
Company overview · Stock price · Financial data · All IR
